Jazz Pharmaceuticals reported a 37.1% EPS surprise, beating market expectations. Revenue grew by 7% year-over-year, driven by strong product sales. Stock declined 0.44% in after-hours trading despite ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results